4//SEC Filing
ENRIGHT PATRICK G 4
Accession 0001415889-24-024046
CIK 0001709941other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 4:26 PM ET
Size
12.1 KB
Accession
0001415889-24-024046
Insider Transaction Report
Form 4
ENRIGHT PATRICK G
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-09-25+15,000→ 15,000 totalExercise: $18.00Exp: 2034-09-24→ Common Stock (15,000 underlying) - Conversion
Series D Preferred Stock
2024-09-27−5,848,637→ 0 total(indirect: Longitude Venture Partners IV, L.P.)→ Common Stock (1,310,589 underlying) - Conversion
Common Stock
2024-09-27+1,310,589→ 1,310,589 total(indirect: Longitude Venture Partners IV, L.P.) - Purchase
Common Stock
2024-09-27$18.00/sh+400,000$7,200,000→ 1,710,589 total(indirect: Longitude Venture Partners IV, L.P.)
Footnotes (3)
- [F1]Pursuant to the Issuer's Restated Certificate of Incorporation, upon closing of the Issuer's initial public offering of its Common Stock, each share of Series D Convertible Preferred Stock automatically converted into shares of Common Stock at a ratio of 1-for-0.224084614. The securities have no expiration date.
- [F2]These shares are directly held by Longitude Venture Partners IV, L.P ("LVP IV"). Longitude Capital Partners IV, LLC ("LCP IV") is the general partner of LVP IV and may be deemed to exercise voting and investment discretion with respect to securities held by LVP IV. The reporting person and Ms. Juliet Tammenoms Bakker serve as the managing members of LCP IV and may be deemed to share voting and investment discretion with respect to securities held directly by LVP IV. Each of LCP IV, Mr. Enright, and Ms. Tammenoms Bakker disclaims beneficial ownership of such securities and this report shall not be deemed an admission that any of them is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, except to the extent of their respective pecuniary interests therein.
- [F3]The entire option award shall vest on the earlier of: (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date.
Documents
Issuer
BioAge Labs, Inc.
CIK 0001709941
Entity typeother
Related Parties
1- filerCIK 0001253886
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 4:26 PM ET
- Size
- 12.1 KB